Your browser doesn't support javascript.
loading
Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
Leuk Lymphoma ; 52(3): 521-4, 2011 Mar.
Article in En | MEDLINE | ID: mdl-21133726

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation / Antineoplastic Combined Chemotherapy Protocols / Methotrexate / Central Nervous System Neoplasms / Cytarabine / Lymphoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2011 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation / Antineoplastic Combined Chemotherapy Protocols / Methotrexate / Central Nervous System Neoplasms / Cytarabine / Lymphoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2011 Document type: Article Country of publication: Estados Unidos